NASDAQ · Biotechnology

Virax Biolabs Group Limited Ordinary Shares (VRAX)

$1.21 -8.33%

27 Oversold Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$4.45-72.81%

Company profile

Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom.

SectorHealthcare

IndustryBiotechnology

Market cap$2.42M

P/E ratioNone

EPS$-12.64

Beta1.386

Dividend yield0.00%

52-week high$21.75

52-week low$1.72

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IOVA Iovance Biotherapeutics Inc RSI 30 GOVX Geovax Labs Inc RSI 17 ARTL Artelo Biosciences Inc RSI 29 ZVSA ZyVersa Therapeutics Inc RSI 15 SKYE Skye Bioscience Inc RSI 31 IMNN Imunon Inc RSI 36 ACXP Acurx Pharmaceuticals Inc RSI 27

30 days of PRO Unlimited free, no card

RSI alerts for VRAX

An email when VRAX closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 9:51 PM EDT